This study revealed that adiponectin facilitates the therapeutic efficiency of thrombopoietic agents by stimulating the membrane trafficking of c‐Mpl in MKs, which provides a point for ITP therapy. The gene discussed is MPL; the disease is autoimmune thrombocytopenic purpura.